期刊文献+

心房颤动急诊患者的现状调查 被引量:17

Retrospective Analysis of 944 Atrial Fibrillation Patients in Emergency Room
下载PDF
导出
摘要 目的:探讨心房颤动(房颤)急诊患者的病因、临床特点及治疗现状。方法:对我院2006-01至2006-12在急诊就诊的房颤患者按时间均衡抽样后,随机选择944例患者对其年龄、房颤史、原发疾病、超声心动图及抗心律失常、抗凝等用药情况进行回顾性分析。结果:入选944例房颤患者中,年龄为15~97岁,男女比例1∶0.88;房颤病因中,<45岁年龄段、45~64岁年龄段的最常见病因为风湿性心脏病,≥65岁年龄段患者的常见病因为高血压,全部944例患者最常见病因为风湿性心脏病。944例患者中孤立性房颤为200例(21.2%)。非瓣膜性房颤患者中,阵发性房颤患者左心房直径均显著小于持续性房颤和永久性房颤患者(P均<0.001),左心室射血分数显著高于持续性房颤和永久性房颤患者(P均<0.001),差异均有统计学意义。阵发性房颤患者心功能Ⅱ-Ⅳ级所占比例较持续性房颤和永久性房颤患者均明显减少(P均<0.001),差异均有统计学意义。全部房颤患者的药物治疗方面,使用β阻滞剂404例(42.7%),地高辛389例(41.2%),非二氢吡啶钙拮抗剂163例(17.3%),胺碘酮59例(6.3%),IC类药物54例(5.7%)。全部患者中合并血栓栓塞者79例(8.4%),其中使用华法林抗凝者有23例(29.1%)。瓣膜性房颤患者中用华法林抗凝有160例(48.2%);非瓣膜性房颤患者中用华法林抗凝有43例(7.1%)。结论:急诊房颤患者的病因、临床特点与国内一般人群的情况基本相似,药物治疗中以控制心室率为主;血栓栓塞是房颤重要的并发症,抗凝治疗需要进一步加强。 Objective :To retrospectively analyze the clinical characteristics and treatment of atrial fibrillation (AF) patients in emergency room in our hospital. Methods:The clinical data of 944 AF patients treated in the emergency room of our hospital in 2006 were selected and analyzed retrospectively. Results:The enrolled patients' age were 19-97 years old, male to female ratio was 0 88: 1. The primary pathogenic cause of AF was rheumatic heart disease, the second and third causes were hypertension and coronary artery disease respectively. About 20% of patients had lone AF. In non-valvular AF patients, the left atrium diameter in paroxysmal AF patients was smaller than in persistent AF and permanent AF patients (P 〈 0. 001 respectively). The left ventrieular ejection fraction and cardiac function were both higher in paroxysmal AF patients than in persistent AF and permanent AF patients (P 〈 0.001 respectively). For all the enrolled patients ,79 ( 8.4% ) cases combined with thromboembolism including ischemic stroke and systemic embolism and 23 (29. 1% ) of those patients were treated with warfarin. Conclusion :The pathogenic causes and clinical characteristics for AF patients selected in our emergency room were similar to the results from other studies. The rate-control strategy was the most common treatment. Thromboembolism was a significant morbidity in AF, it was necessary to emphasize the importance of anticoagulation therapy.
出处 《中国循环杂志》 CSCD 北大核心 2009年第1期40-44,共5页 Chinese Circulation Journal
关键词 心房颤动 急诊 现状 Atrial fibrillation Emergency room Status
  • 相关文献

参考文献13

  • 1Benjamin EJ,Levy D,Vaziri SM,et al.Independent risk factors for atrial fibrillation in a populatian-based cohort.The Framingham Heart Study.JAMA,1994,271:840-844.
  • 2Go AS,Hylek EM,Phillips KA,et al.Prevalence of diagaosed atrial fibrillation in adults:national implications for rhythm management and stroke prevention:the AnTicongalation and Risk Factors in Atrial Fibrillation (ATRIA) Study.JAMA,2001,285:2370-2375.
  • 3Stewart S,Hart CL,Hole D J,et al.A pepulation-besed study of the long-term risks associated with atrial fibrillatian:20-year follow-up of the Renfrew/Paisley study.Am J Mad,2002,113:359-364.
  • 4龚艳君,丁文惠,丁燕生,杨玲,吴建芳.1335例心房颤动住院患者病因(或相关因素)分析[J].中华老年心脑血管病杂志,2006,8(10):658-661. 被引量:17
  • 5薛玉梅,刘震,吴书林.心房颤动住院患者1650例临床分析[J].中国实用内科杂志,2003,23(4):216-218. 被引量:37
  • 6Feinberg WM,Cornell ES,Nightingale SD,et al.Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation.Stroke prevention in atrial fibrillation investigators.Stroke,1997,28:1101-1106.
  • 7Murgatroyd FD,Gibsan SM,Baiyan X,et al.Double-blind placebocontrolled trial of digoxin in symptomatic paroxysmal atrial fibrillation.Circulation,1999,99:2765-2770.
  • 8Alessie M,Ausma J,Schotten U.Electrical contractile and structural remodeling during atrial fibrillation.Cardiovasc Res,2002,54:230-246.
  • 9van Gelder IC,Hagans BE,Bosker HA,et al.A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.N Engl J Med,2002,347:1834-1840.
  • 10Tamariz LJ,Bass EB.Pharmacological rate control of atrial fibrillation.Cardiol Clin,2004,22:35-45.

二级参考文献22

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2[1]Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study[J]. N Engl J Med, 1982, 306:1018~1022
  • 3[2]Stewart S, Maclntyre K, Macleod MMC, et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996[J]. Eur Heart J, 2001, 22(8): 693~701
  • 4[3]Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. Circulation, 1999, 99: 3028-3035
  • 5[4]Igarashi Y, Kasai H, Yamashita F, et al. Lipoprotein(a), left atrial appendage function and thromboembolic risk in patients chronic non-valvular atrial fibrillation[J]. Jpn Circ J, 2000, 64: 93~98
  • 6[5]Petersen P. Thromboembolic complications in atrial fibrillation[J]. Stroke, 1990, 21: 4~13
  • 7[6]Wolf PA, Abbott RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham study[J]. Stroke, 1991, 22: 983~988
  • 8[7]Hart RG,Benavent O,MeBride R,et al.Antithrombotic therapy to prevent stroke in patients with atrial fibrillation:a meta-analysis[J].Ann Intern Med,1999,131:492~501
  • 9[8]Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation[J]. Stroke, 2000, 31: 822~827
  • 10Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. Tile Framingham Heart Study[J]. JAMA, 1994,271:840-844.

共引文献52

同被引文献173

引证文献17

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部